SBFM
SBFM
NASDAQ · Biotechnology

Sunshine Biopharma Inc

$1.20
+0.05 (+4.35%)
As of Feb 8, 2:31 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 953.7K 857.2K 883.5K
Net Income 90.7K 81.5K 110.3K
EPS
Profit Margin 9.5% 9.5% 12.5%
Rev Growth +23.3% +22.6% +12.8%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 3.14M 2.46M 3.00M
Total Equity 4.51M 5.12M 4.93M
D/E Ratio 0.69 0.48 0.61
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 169.7K 158.3K 158.7K
Free Cash Flow 104.6K 58.4K 79.5K